Diabetic lung disease: fact or fiction?

Kolahian, Saeed; Leiss, Veronika; Nürnberg, Bernd

Kolahian, Saeed; Leiss, Veronika; Nürnberg, Bernd.

Afiliación

Kolahian S; Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, and Interfaculty Center of Pharmacogenomics and Drug Research (ICePhA), Eberhard Karls University Hospitals and Clinics, Tübingen, Germany. Saeed.Kolahian@med.uni-tuebingen.de.
Leiss V; Department of Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, Tübingen, Germany. Saeed.Kolahian@med.uni-tuebingen.de.
Nürnberg B; Department of Pharmacogenomics, University of Tübingen, Wilhelmstrasse. 56, D-72074, Tübingen, Germany. Saeed.Kolahian@med.uni-tuebingen.de.

Rev Endocr Metab Disord ; 20(3): 303-319, 2019 09.

Article en En | MEDLINE | ID: mdl-31637580

Asunto(s)

Diabetes Mellitus/fisiopatología; Enfermedades Pulmonares/etiología; Complicaciones de la Diabetes; Humanos; Fibrosis Pulmonar/etiología

Palabras clave

Diabetes mellitus; Fibrosis; Lung; Pulmonary disease

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus / Enfermedades Pulmonares Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Rev Endocr Metab Disord Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google